(Q39916702)

15 September 2017

title

Evaluation of direct medical costs of hospitalization for febrile neutropenia (English)

1 reference

15 September 2017

1 reference

3

1 reference

15 September 2017

Nina Lathia

1

1 reference

15 September 2017

Nicole Mittmann

2

1 reference

15 September 2017

Sandra Knowles

4

1 reference

15 September 2017

Matthew Cheung

5

1 reference

15 September 2017

Eugenia Piliotis

6

1 reference

15 September 2017

Neil Shear

7

1 reference

15 September 2017

Scott Walker

8

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

15 September 2017

1 reference

15 September 2017

volume

116

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

742-748

1 reference

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24773

Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24773

7 January 2021

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24773

7 January 2021

Planned progressive antimicrobial therapy in neutropenic patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24773

7 January 2021

Economic analyses of toxicity secondary to anthracycline-based breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24773

7 January 2021

Pharmacoeconomic analysis of empirical therapy with ceftazidime alone or combination antibiotics for febrile neutropenia in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24773

7 January 2021

A pilot study to evaluate the feasibility of using willingness to pay as a measure of value in cancer supportive care: an assessment of amifostine cytoprotection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24773

7 January 2021

Cost-benefit analysis of prophylactic granulocyte colony-stimulating factor during CHOP antineoplastic therapy for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24773

7 January 2021

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24773

7 January 2021

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24773

7 January 2021

Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24773

7 January 2021

Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24773

7 January 2021

Economic evaluations of granulocyte colony-stimulating factor: in the prevention and treatment of chemotherapy-induced neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24773

7 January 2021

Identifiers

DOI

10.1002/CNCR.24773

1 reference

15 September 2017

1 reference